References
- Alvarado-Mora, M. V., Fernandez, M. F. G., Gomes-Gouvêa, M. S., de Azevedo Neto, R. S., Carrilho, F. J., & Pinho, J. R. R. (2011). Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population–how is the epidemiological situation? Plos One, 6(4), e18888–e18888. http://doi.org/10.1371/journal.pone.0018888
- Berbesi, D., Montoya, L., & Segura, A. (2012). Prevalencia de VIH y comportamientos de riesgo en UDI en Medellin y Pereira. Bogota: Ministerio de Proteccion Social.
- Bruggmann, P., & Grebely, J. (2014). Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. The International Journal on Drug Policy. http://doi.org/10.1016/j.drugpo.2014.08.014
- Chu, T. X., & Levy, J. A. (2005). Injection drug use and HIV/AIDS transmission in China. Cell Research, 15(11–12), 865–869. http://doi.org/10.1038/sj.cr.7290360
- Day, C. A., White, B., Thein, H. H., Doab, A., Dore, G. J., Bates, A., … Maher, L. (2008). Experience of hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care, 20(1), 116–123. http://doi.org/10.1080/09540120701426524
- di Filippo, D., Cortes-Mancera, F., Beltran, M., Arbelaez, M. P., Jaramillo, S., Restrepo, J. C., … Navas, M.-C. (2012). Molecular characterization of hepatitis c virus in multi-transfused Colombian patients. Virology Journal, 9, 242. http://doi.org/10.1186/1743-422X-9-242
- Garfein, R. S., Rondinelli, A., Barnes, R. F. W., Cuevas, J., Metzner, M., Velasquez, M., … Teshale, E. H. (2013). HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 90(3), 516–528. http://doi.org/10.1007/s11524-012-9728-0
- Graham, C. S., & Swan, T. (2015). A Path to Eradication of Hepatitis C in Low-and Middle-Income Countries. Antiviral Research. http://doi.org/10.1016/j.antiviral.2015.01.004
- Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011). A systematic review and meta-analysis of interventions to prevent Hepatitis C virus infection in people who inject drugs. Journal of Infectious Diseases, 204(1), 74–83. http://doi.org/10.1093/infdis/jir196
- Harris, M., & Rhodes, T. (2013). Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduction Journal, 10, 7. http://doi.org/10.1186/1477-7517-10-7
- Harris, R. J., Ramsay, M., Hope, V. D., Brant, L., Hickman, M., Foster, G. R., & De Angelis, D. (2012). Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. European Journal of Public Health, 22(2), 187–192. http://doi.org/10.1093/eurpub/ckr083
- Hurley, S. F., Jolley, D. J., & Kaldor, J. M. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349(9068), 1797–1800. http://doi.org/10.1016/S0140-6736(96)11380-5
- Kassaian, N., Adibi, P., Kafashaian, A., Yaran, M., Nokhodian, Z., Shoaei, P., … Ataei, B. (2012). Hepatitis C virus and associated risk factors among prison inmates with history of drug injection in Isfahan, Iran. International Journal of Preventive Medicine, 3, S156–S161.
- Kerr, T., Small, W., Buchner, C., Zhang, R., Li, K., Montaner, J., & Wood, E. (2010). Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. American Journal of Public Health, 100(8), 1449–1453. http://doi.org/10.2105/AJPH.2009.178467
- Klevens, R. M., Hu, D. J., Jiles, R., & Holmberg, S. D. (2012). Evolving epidemiology of hepatitis C virus in the United States. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 55(Suppl 1), S3–S9. http://doi.org/10.1093/cid/cis393
- McCreesh, N., Copas, A., Seeley, J., Johnston, L. G., Sonnenberg, P., Hayes, R. J., … White, R. G. (2013). Respondent driven sampling: determinants of recruitment and a method to improve point estimation. Plos One, 8(10), e78402–e78402. http://doi.org/10.1371/journal.pone.0078402
- Mejía, I. E., & Gómez, A. P. (2005). La inyección de drogas en Bogotá: una amenaza creciente. Adicciones, 17(3), 251–260.
- Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013). Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, Md.), 57(4), 1333–1342. http://doi.org/10.1002/hep.26141
- Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011). Glbal epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet, 378(9791), 571–583. http://doi.org/10.1016/S0140-6736(11)61097-0
- Nokhodian, Z., Meshkati, M., Adibi, P., Ataei, B., Kassaian, N., Yaran, M., … Hassannejad, R. (2012). Hepatitis C among intravenous drug users in Isfahan, Iran: a study of seroprevalence and risk factors. International Journal of Preventive Medicine, 3(Suppl 1), S131–S138.
- Pérez Guevara, M. T., Rolo Gómez, F. M., Nibot Sánchez, C., Cruz Sui, O., & Rodríguez, O. (1998). Determinación de anticuerpos al virus de la inmunodeficiencia humana tipo 1 (VIH-1) en muestras de sangre seca en papel de filtro. Revista Cubana de Medicina Tropical, 50(2), 93–95.
- Reid, S. R. (2009). Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduction Journal, 6, 24. http://doi.org/10.1186/1477-7517-6-24
- Respondent Driven Sampling. (s/f). Recuperado el 8 de julio de 2014, a partir de http://www.respondentdrivensampling.org/
- Ross, M. W., McCurdy, S. A., Kilonzo, G. P., Williams, M. L., & Leshabari, M. T. (2008). Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. The American Journal of Tropical Medicine and Hygiene, 79(3), 338–343.
- Solomon, S. S., Mehta, S. H., Srikrishnan, A. K., Solomon, S., McFall, A. M., Laeyendecker, O., … Quinn, T. C. (2015). Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. The Lancet: Infectious Diseases, 15(1), 36–45. http://doi.org/10.1016/S1473-3099(14)71045-X
- Waheed, Y., Shafi, T., Safi, S. Z., & Qadri, I. (2009). Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World Journal of Gastroenterology: WJG, 15(45), 5647–5653.